0001818382-23-000084.txt : 20230616
0001818382-23-000084.hdr.sgml : 20230616
20230616160937
ACCESSION NUMBER: 0001818382-23-000084
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230615
FILED AS OF DATE: 20230616
DATE AS OF CHANGE: 20230616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Niklason Laura E
CENTRAL INDEX KEY: 0001878075
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39532
FILM NUMBER: 231021150
MAIL ADDRESS:
STREET 1: 35 WILSHIRE ROAD
CITY: GREENWICH
STATE: CT
ZIP: 06831
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Humacyte, Inc.
CENTRAL INDEX KEY: 0001818382
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851763759
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919-313-9633
MAIL ADDRESS:
STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54
CITY: DURHAM
STATE: NC
ZIP: 27713
FORMER COMPANY:
FORMER CONFORMED NAME: Alpha Healthcare Acquisition Corp.
DATE OF NAME CHANGE: 20200716
4
1
wf-form4_168694616392845.xml
FORM 4
X0407
4
2023-06-15
0
0001818382
Humacyte, Inc.
HUMA
0001878075
Niklason Laura E
2525 EAST NORTH CAROLINA HIGHWAY 54
DURHAM
NC
27713
1
1
1
0
President, CEO and Director
0
Stock Options (right to buy)
3.35
2023-06-15
4
A
0
8500
0
A
2033-06-15
Common Stock
8500.0
8500
I
By spouse
The first 25% of the option becomes exercisable on June 15, 2024, after which 1/48 of the option will become exercisable on the 15th of each month through June 15, 2027.
/s/ Laura E. Niklason by Dale A. Sander as Attorney-in-Fact
2023-06-16